Status labels apply within the product, route, and use described below. Read the limitations alongside that scope.
- Scoped product status
- Not FDA-approved
- Evidence label
- Randomized evidence
Status as of
Reference fields
Sources for these fields
- Product and use
- The reviewed FDA record identifies no approved ipamorelin product.
- Route context
- The cited trial used intravenous treatment after bowel surgery.
- Mechanism
- A ghrelin-receptor agonist.
- Evidence
- A randomized postoperative-ileus trial did not show a significant efficacy advantage.
- Limitations
- That setting does not establish anti-aging or muscle-building benefit.
- Safety
- FDA flags safety uncertainties for injectable ipamorelin.
Sources
These references support the fields as a group. Follow a source to check the original wording and its scope.
- FDA safetyFDA · Checked
- FDA ipamorelinFDA · Checked
- BeckPubMed · Checked
Continue reading
Reading topics: Hormones. These organize the library and do not describe recommended uses.
Educational reference information. No clinician review is claimed. This entry does not provide personal medical advice.